Mind Medicine (MindMed) Short Interest Data
- Current Short Volume
- 5,870,000 shares
- Previous Short Volume
- 4,220,000 shares
- Change Vs. Previous Month
- +39.10%
- Dollar Volume Sold Short
- $53.83 million
- Short Interest Ratio / Days to Cover
- 3.2
- Last Record Date
- March 15, 2024
- Outstanding Shares
- 70,270,000 shares
- Float Size
- 27,060,000 shares
- Short Percent of Float
- 21.69%
- Today's Trading Volume
- 3,331,346 shares
- Average Trading Volume
- 2,043,352 shares
- Today's Volume Vs. Average
- 163%
Short Selling Mind Medicine (MindMed) ?
Sign up to receive the latest short interest report for Mind Medicine (MindMed) and its competitors with MarketBeat's FREE newsletter.
Short InterestDays to CoverShort Percent of Float
MNMD Short Interest Over Time
MNMD Days to Cover Over Time
MNMD Percentage of Float Shorted Over Time
Mind Medicine (MindMed) Short Interest History
| Report Date | Total Shares Sold Short | Dollar Volume Sold Short | Change from Previous Report | Percentage of Float Shorted | Days to Cover | Price on Report Date |
|---|---|---|---|---|---|---|
| 3/15/2024 | 5,870,000 shares | $53.83 million | +39.1% | 21.7% | 3.2 | $9.17 |
| 2/29/2024 | 4,220,000 shares | $24.12 million | +23.0% | 16.1% | 2.8 | $5.72 |
| 2/15/2024 | 3,430,000 shares | $15.71 million | +7.5% | 13.2% | 4.9 | $4.58 |
| 1/31/2024 | 3,190,000 shares | $12.31 million | -0.9% | 12.3% | 5.4 | $3.86 |
| 1/15/2024 | 3,220,000 shares | $12.75 million | +2.6% | 12.4% | 5.7 | $3.96 |
| 12/31/2023 | 3,140,000 shares | $11.49 million | +11.7% | 12.1% | 5.8 | $3.66 |
Get the Latest News and Ratings for MNMD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Mind Medicine (MindMed) and its competitors with MarketBeat's FREE daily newsletter. | ||||||
| 12/15/2023 | 2,810,000 shares | $9.41 million | +12.9% | 10.6% | 5.5 | $3.35 |
| 11/30/2023 | 2,490,000 shares | $8.22 million | -10.1% | 9.4% | 6.3 | $3.30 |
| 11/15/2023 | 2,770,000 shares | $7.17 million | -3.8% | 10.5% | 7.3 | $2.59 |
| 10/31/2023 | 2,880,000 shares | $7.37 million | -8.0% | 11.1% | 7.5 | $2.56 |
| 10/15/2023 | 3,130,000 shares | $8.76 million | -1.9% | 12.1% | 7.3 | $2.80 |
| 9/30/2023 | 3,190,000 shares | $9.98 million | -3.6% | 12.3% | 6 | $3.13 |
| 9/15/2023 | 3,310,000 shares | $13.80 million | +3.8% | 12.8% | 5.7 | $4.17 |
| 8/31/2023 | 3,190,000 shares | $13.24 million | -5.1% | 12.4% | 5.4 | $4.15 |
| 8/15/2023 | 3,360,000 shares | $14.11 million | -1.2% | 13.0% | 5.9 | $4.20 |
| 7/31/2023 | 3,400,000 shares | $16.76 million | +13.7% | 13.2% | 6.1 | $4.93 |
| 7/15/2023 | 2,990,000 shares | $11.90 million | -2.3% | 11.6% | 5.9 | $3.98 |
| 6/30/2023 | 3,060,000 shares | $10.92 million | +3.4% | 11.9% | 6 | $3.57 |
| 6/15/2023 | 2,960,000 shares | $10.98 million | +4.6% | 11.1% | 7 | $3.71 |
| 5/31/2023 | 2,830,000 shares | $10.02 million | -0.4% | 10.7% | 7.2 | $3.54 |
| 5/15/2023 | 2,840,000 shares | $8.97 million | No Change | 10.7% | 7.1 | $3.16 |
| 10/31/2022 | 1,700,000 shares | $4.98 million | +70.0% | 0.4% | 1.2 | $2.93 |
| 10/15/2022 | 1,000,000 shares | $2.89 million | -32.0% | 0.3% | 0.7 | $2.89 |
| 9/30/2022 | 1,470,000 shares | $5.15 million | +52.5% | 0.4% | 1.2 | $3.50 |
| 9/15/2022 | 963,800 shares | $7.25 million | +13.8% | 0.2% | 1.1 | $7.52 |
| 8/31/2022 | 846,700 shares | $9.92 million | -95.0% | 0.2% | 1.1 | $11.72 |
| 8/15/2022 | 16,990,000 shares | $11.89 million | -9.9% | 4.8% | 1.8 | $0.70 |
| 7/31/2022 | 18,850,000 shares | $13.10 million | +2.1% | 5.3% | 6.6 | $0.69 |
| 7/15/2022 | 18,460,000 shares | $12.67 million | -10.2% | 5.2% | 6.3 | $0.69 |
| 6/30/2022 | 20,560,000 shares | $13.16 million | -42.1% | N/A | 6.7 | $0.64 |
| 6/15/2022 | 35,530,000 shares | $27.09 million | -5.1% | 10.1% | 11.3 | $0.76 |
| 5/31/2022 | 37,440,000 shares | $33.87 million | -1.8% | 10.6% | 14.5 | $0.90 |
| 5/15/2022 | 38,140,000 shares | $29.75 million | +18.3% | 10.7% | 14.4 | $0.78 |
| 4/30/2022 | 32,230,000 shares | $25.78 million | +5.4% | 9.0% | 10.5 | $0.80 |
| 4/15/2022 | 30,580,000 shares | $29.66 million | +11.3% | 8.7% | 7.4 | $0.97 |
| 3/31/2022 | 27,480,000 shares | $30.50 million | +2.8% | 7.8% | 6.4 | $1.11 |
| 3/15/2022 | 26,720,000 shares | $27.52 million | -0.5% | 7.5% | 5.8 | $1.03 |
| 2/28/2022 | 26,850,000 shares | $32.76 million | +3.2% | 7.5% | 5.6 | $1.22 |
| 2/15/2022 | 26,020,000 shares | $34.87 million | +10.8% | 7.3% | 5.2 | $1.34 |
| 1/31/2022 | 23,480,000 shares | $26.30 million | +30.1% | 6.6% | 4.6 | $1.12 |
| A.I. is a Tidal Wave - Here’s What to Buy (Ad)The internet generated more wealth than any other innovation in history - creating hundreds of thousands of new millionaires in America alone.Now A.I. could do the same. But if you're buying Microsoft or NVIDIA to profit - you're missing the big picture.Get the name and ticker symbol for free - just click here. | ||||||
MNMD Short Interest - Frequently Asked Questions
What is Mind Medicine (MindMed)'s current short interest?
Short interest is the volume of Mind Medicine (MindMed) shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 5,870,000 shares of MNMD short. 21.69% of Mind Medicine (MindMed)'s shares are currently sold short. Learn More on Mind Medicine (MindMed)'s current short interest.
What is a good short interest ratio for Mind Medicine (MindMed)?
The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MNMD shares currently have a short interest ratio of 3.0. Learn More on Mind Medicine (MindMed)'s short interest ratio.
Which institutional investors are shorting Mind Medicine (MindMed)?
As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Mind Medicine (MindMed): GTS Securities LLC, Wolverine Trading LLC, Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.
What is a good short interest percentage for Mind Medicine (MindMed)?
Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 21.69% of Mind Medicine (MindMed)'s floating shares are currently sold short.
Is Mind Medicine (MindMed)'s short interest increasing or decreasing?
Mind Medicine (MindMed) saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 5,870,000 shares, an increase of 39.1% from the previous total of 4,220,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
What is Mind Medicine (MindMed)'s float size?
Mind Medicine (MindMed) currently has issued a total of 70,270,000 shares. Some of Mind Medicine (MindMed)'s outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mind Medicine (MindMed) currently has a public float of 27,060,000 shares.
How does Mind Medicine (MindMed)'s short interest compare to its competitors?
21.69% of Mind Medicine (MindMed)'s shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Mind Medicine (MindMed): Canopy Growth Co. (7.16%), USANA Health Sciences, Inc. (2.26%), biote Corp. (2.27%), Cronos Group Inc. (3.24%), Aurora Cannabis Inc. (24.50%), ChromaDex Co. (2.62%), Verve Therapeutics, Inc. (25.73%), Allogene Therapeutics, Inc. (26.58%), SIGA Technologies, Inc. (13.70%), Cogent Biosciences, Inc. (10.07%),
Which stocks are the most shorted right now?
As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks.
What does it mean to sell short Mind Medicine (MindMed) stock?
Short selling MNMD is an investing strategy that aims to generate trading profit from Mind Medicine (MindMed) as its price is falling. MNMD shares are trading down $0.46 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Mind Medicine (MindMed)?
A short squeeze for Mind Medicine (MindMed) occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MNMD, which in turn drives the price of the stock up even further.
How often is Mind Medicine (MindMed)'s short interest reported?
Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MNMD, twice per month. The most recent reporting period available is March, 15 2024.
More Short Interest Resources from MarketBeat
Related Companies:
- Canopy Growth Short Interest
- USANA Health Sciences Short Interest
- biote Short Interest
- Cronos Group Short Interest
- Aurora Cannabis Short Interest
- ChromaDex Short Interest
- Verve Therapeutics Short Interest
- Allogene Therapeutics Short Interest
- SIGA Technologies Short Interest
- Cogent Biosciences Short Interest
Short Interest Tools:
- Stocks to Short
- Largest Short Interest Positions
- Short Interest Increases
- Short Interest Decreases
- Short Interest Reporting Dates
